Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer September 2022 23(6):498-509 - Subject
- Language
- ISSN
- 1525-7304